Physician profile
Stephen Dunay
NPI 1336487834
$5,758.07
in general payments reported to CMS, 2019-2025
7 companies · $2,899 in 2025
The $2,899 reported for 2025 was more than what 84% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $832 · 2022: $200 · 2024: $1,827 · 2025: $2,899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,844 · Consulting Fee: $930 · Food and Beverage: $924 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,843.65 |
| Consulting Fee | $930.00 |
| Food and Beverage | $924.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,969.21 | 2025 | Proclaim, Durata |
| Medtronic, INC. | $1,727.29 | 2024 | Intellis Adaptivestim |
| Masimo Corporation | $930.00 | 2025 | |
| Eko Health, INC. | $599.00 | 2021-2022 | |
| Becton, Dickinson and Company | $436.33 | 2021-2024 | Sherlock |
| Spr Therapeutics, INC | $71.41 | 2024 | Sprint Pns System |
| Csl Behring | $24.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Dunay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.